Page last updated: 2024-08-24

fluorodeoxyglucose f18 and etomoxir

fluorodeoxyglucose f18 has been researched along with etomoxir in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agarwal, R; Boyle, KE; Cramer, SD; Deep, G; Eckel, RH; Glodé, LM; Hitz, CA; Lucia, SM; Maroni, P; Pac, CT; Schlaepfer, IR; Serkova, NJ	1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and etomoxir

Article	Year
Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts. Molecular imaging and biology, 2015, Volume: 17, Issue:4 Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Epoxy Compounds; Fluorodeoxyglucose F18; Glucose; Heterografts; Humans; Hypoglycemic Agents; Lipid Metabolism; Male; Mice; Mice, Nude; Oxidation-Reduction; Positron-Emission Tomography; Prostatic Neoplasms	2015

Article

Year

Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse Xenografts.

Molecular imaging and biology, 2015, Volume: 17, Issue:4

Topics: Animals; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Epoxy Compounds; Fluorodeoxyglucose F18; Glucose; Heterografts; Humans; Hypoglycemic Agents; Lipid Metabolism; Male; Mice; Mice, Nude; Oxidation-Reduction; Positron-Emission Tomography; Prostatic Neoplasms

2015